Global Malaria Eradication Programme

Global Malaria Eradication Programme The Global Malaria Eradication Programme (GMEP) was a campaign launched by the World Health Organization (WHO) in 1955 to eradicate malaria globally. The program was a response to the significant burden of malaria, which was estimated to affect around 300 million people annually at the time. The WHO's efforts were supported by various governments, United Nations agencies, and other international organizations. The program's ambitious goal was to eliminate malaria, a disease caused by Plasmodium parasites transmitted through the bites of infected Anopheles mosquitoes.

Background and launch

The GMEP was launched in 1955, following a series of successful pilot projects and research initiatives led by scientists such as Paul Müller, who had discovered the insecticidal properties of DDT in the 1940s. The WHO's malaria eradication efforts were also influenced by the work of Alexander Bogdanovitch Fyodorovich, a Russian scientist who had developed methods for controlling mosquito populations. The program's launch was facilitated by the availability of DDT, which was seen as a powerful tool for controlling mosquito populations and reducing malaria transmission.

Strategy and implementation

The GMEP's strategy involved a multi-faceted approach, including vector control through the use of insecticides, surveillance, and case management. The program focused on using DDT to control mosquito populations, as well as implementing public health measures such as quarantine and contact tracing. The WHO worked closely with national governments, United Nations Children's Fund (UNICEF), and other international organizations to implement the program. In countries such as India, Brazil, and Sudan, the program involved large-scale spraying of DDT and other insecticides, as well as the distribution of antimalarial drugs.

Outcomes and challenges

The GMEP achieved significant successes in the 1960s, with many countries reporting substantial reductions in malaria cases and deaths. For example, in Ceylon (now Sri Lanka), malaria cases declined from 2.5 million in 1956 to just 50 in 1963. However, the program faced several challenges, including the development of insecticide resistance among mosquito populations, as well as the emergence of drug-resistant Plasmodium strains. The program also struggled with issues of sustainability, as many countries faced difficulties in maintaining the high levels of funding and resources required to support the eradication efforts.

Legacy and subsequent initiatives

Despite the challenges faced by the GMEP, the program laid the groundwork for subsequent malaria control initiatives. The WHO's Roll Back Malaria partnership, launched in 1998, built on the lessons learned from the GMEP to develop more sustainable and integrated approaches to malaria control. Other initiatives, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, have also been established to support global efforts to control and eliminate malaria. The GMEP's legacy can also be seen in the development of new antimalarial drugs and vaccines, such as the RTS,S vaccine, which was approved for use in 2019.

Criticism and lessons learned

The GMEP has been subject to criticism for its over-reliance on DDT and its failure to adequately address issues of sustainability and community engagement. The program's focus on eradication, rather than control, has also been questioned by some experts, who argue that a more pragmatic approach may have been more effective in the long term. Despite these challenges, the GMEP remains an important example of global cooperation and coordination in the fight against infectious diseases. The program's lessons have informed subsequent global health initiatives, including the development of more integrated and sustainable approaches to disease control. Category:Malaria Category:Global health Category:World Health Organization